Maurizio Porcu

1: Manca P, Cannatà A, Nuzzi V, Bromage DI, Varrà GG, Rossi M, Ferro MD, PaldinoA, Gigli M, Barbati G, Ramani F, Pinamonti B, Stolfo D, Porcu M, Mestroni L,Merlo M, Sinagra G. Prevalence and evolution of right ventricular dysfunctionamong different genetic backgrounds in dilated cardiomyopathy. Can J Cardiol.2021 Jul 14:S0828-282X(21)00369-X. doi: 10.1016/j.cjca.2021.06.024. Epub aheadof print. PMID: 34273475. 2: Porcu M, Corda M, Pasqualucci D, Binaghi G, Sanna N, Matta G, Cossa S,Scalone A, Tola G. A very long-term observation of a family with dilatedcardiomyopathy and overlapping phenotype from lamin A/C mutation. J CardiovascMed (Hagerstown). 2021 Jan;22(1):53-58. doi: 10.2459/JCM.0000000000001060. PMID:32740430. 3: Binaghi G, Cossa S, Pasqualucci D, Piras M, Porcu M. An Unusual Case of AcuteHeart Failure: Myositis With Cardiac Involvement as the First ClinicalManifestation of a Possible Connective Tissue Disease. J Clin Rheumatol. 2020Dec 8. doi: 10.1097/RHU.0000000000001629. Epub ahead of print. PMID: 33298809. 4: Manca P, Cossa S, Matta G, Scalone A, Tola G, Schintu B, Setzu A, Melis M,Giardina A, Corda M, Sinagra G, Porcu M. Right ventricular function assessed bycardiac magnetic resonance predicts the response to resynchronization therapy. JCardiovasc Med (Hagerstown). 2020 Apr;21(4):299-304. doi:10.2459/JCM.0000000000000931. PMID: 32108126. 5: Di Pasquale G, Iacovoni A, Filardi PP, Giustozzi M, De Ponti R, Falanga A,Botto GL, De Filippo P, Gavazzi A, Sciatti E, Senni M, Porcu M. Grey zonessull’uso dei nuovi anticoagulanti orali nella fibrillazione atriale. Opinionidegli esperti [Grey zones on new oral anticoagulants in atrial fibrillation.Expert opinion]. G Ital Cardiol (Rome). 2020 Feb;21(2):103-110. Italian. doi:10.1714/3300.32703. PMID: 32051633. 6: Deidda M, Piras C, Binaghi G, Congia D, Pani A, Boi A, Sanna F, Rossi A, LoiB, Cadeddu Dessalvi C, Atzori L, Porcu M, Mercuro G. Metabolomic fingerprint ofcoronary blood in STEMI patients depends on the ischemic time and inflammatorystate. Sci Rep. 2019 Jan 22;9(1):312. doi: 10.1038/s41598-018-36415-y. PMID:30670713; PMCID: PMC6342950. 7: Binaghi G, Pasqualucci D, Porcu M. A systematic cardiological screening forseizure-triggered Takotsubo is really useful? J Neurol Sci. 2019 Mar 15;398:192.doi: 10.1016/j.jns.2019.01.015. Epub 2019 Jan 14. PMID: 30661767. 8: Binaghi G, Matta G, Melis M, Pasqualucci D, Porcu M. Recurrent seizure-triggered Takotsubo: A suggestive differential diagnosis. Seizure. 2019Feb;65:177. doi: 10.1016/j.seizure.2018.12.014. Epub 2018 Dec 19. PMID:30594564. 9: Canepa M, Ameri P, Lucci D, Nicolosi GL, Marchioli R, Porcu M, Tognoni G,Franzosi MG, Latini R, Maseri A, Tavazzi L, Maggioni AP; GISSI-HF Investigators.Modes of death and prognostic outliers in chronic heart failure. Am Heart J.2019 Feb;208:100-109. doi: 10.1016/j.ahj.2018.11.009. Epub 2018 Nov 24. PMID:30580128. 10: Binaghi G, Congia D, Cossa S, Ganga R, Giardina G, Matta G, Merella W, MelisM, Pasqualucci D, Serra E, Porcu M. Seizures and recurrence of Takotsubosyndrome: One clinical presentation and trigger, but two different anatomicalvariants in the same patient. A case to meditate on. Seizure. 2018 Dec;63:37-39.doi: 10.1016/j.seizure.2018.10.014. Epub 2018 Oct 26. PMID: 30396042. 11: Atzeni F, Corda M, Gianturco L, Porcu M, Sarzi-Puttini P, Turiel M.Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases. Front Med(Lausanne). 2018 Feb 14;5:26. doi: 10.3389/fmed.2018.00026. PMID: 29497612;PMCID: PMC5819573. 12: Binaghi G, Congia D, Cossa S, Massidda S, Pasqualucci D, Pilo F, Serra E,Angelucci E, Porcu M. Cardiogenic Shock during First Infusion of AnthracyclineChemotherapy in a Patient with Hodgkin Lymphoma: An Unusual Event. Cardiology.2018;139(1):7-10. doi: 10.1159/000480291. Epub 2017 Oct 18. PMID: 29041005. 13: Napp AE, Haase R, Laule M, Schuetz GM, Rief M, Dreger H, Feuchtner G,Friedrich G, Špaček M, Suchánek V, Fuglsang Kofoed K, Engstroem T, Schroeder S,Drosch T, Gutberlet M, Woinke M, Maurovich-Horvat P, Merkely B, Donnelly P, BallP, Dodd JD, Quinn M, Saba L, Porcu M, Francone M, Mancone M, Erglis A, ZvaigzneL, Jankauskas A, Sakalyte G, Harań T, Ilnicka-Suckiel M, Bettencourt N, Gama-Ribeiro V, Condrea S, Benedek I, Čemerlić Adjić N, Adjić O, Rodriguez-PalomaresJ, Garcia Del Blanco B, Roditi G, Berry C, Davis G, Thwaite E, Knuuti J, PietiläM, Kępka C, Kruk M, Vidakovic R, Neskovic AN, Díez I, Lecumberri I, Geleijns J,Kubiak C, Strenge-Hesse A, Do TH, Frömel F, Gutiérrez-Ibarluzea I, Benguria-Arrate G, Keiding H, Katzer C, Müller-Nordhorn J, Rieckmann N, Walther M,Schlattmann P, Dewey M; DISCHARGE Trial Group. Computed tomography versusinvasive coronary angiography: design and methods of the pragmatic randomisedmulticentre DISCHARGE trial. Eur Radiol. 2017 Jul;27(7):2957-2968. doi:10.1007/s00330-016-4620-z. Epub 2016 Nov 18. PMID: 27864607. 14: Binaghi G, Congia D, Dessì C, Matta G, Pasqualucci D, Serra E, Porcu M.Cardiac and thrombotic complications in the peripartum period of a patientaffected by beta-thalassemia intermedia: An unusual case. Int J Cardiol. 2016Jul 15;215:32-3. doi: 10.1016/j.ijcard.2016.04.066. Epub 2016 Apr 13. PMID:27107541. 15: Pasqualucci D, Fornaro A, Castelli G, Rossi A, Arretini A, Chiriatti C,Targetti M, Girolami F, Corda M, Orrù P, Matta G, Stefàno P, Cecchi F, Porcu M,Olivotto I. Clinical Spectrum, Therapeutic Options, and Outcome of AdvancedHeart Failure in Hypertrophic Cardiomyopathy. Circ Heart Fail. 2015Nov;8(6):1014-21. doi: 10.1161/CIRCHEARTFAILURE.114.001843. Epub 2015 Oct 7.PMID: 26446673. 16: Cosmi F, Di Giulio P, Masson S, Finzi A, Marfisi RM, Cosmi D, Scarano M,Tognoni G, Maggioni AP, Porcu M, Boni S, Cutrupi G, Tavazzi L, Latini R; GISSI-HF Investigators. Regular wine consumption in chronic heart failure: impact onoutcomes, quality of life, and circulating biomarkers. Circ Heart Fail. 2015May;8(3):428-37. doi: 10.1161/CIRCHEARTFAILURE.114.002091. Epub 2015 Apr 29.PMID: 25925415. 17: Scorcu G, Meloni L, Pilleri A, Loi B, Pirisi R, Sanna F, Cadeddu M, Serra E,Sori P, Boscarelli D, Iasiello G, Pinna G, Porcu M. La rete per l’emergenzacoronarica nell’Area Vasta di Cagliari: gestione dell’infarto miocardico acutocon sopraslivellamento del tratto ST, analisi dei tempi di riperfusione eaderenza alle linee guida [The network for acute coronary syndromes in themetropolitan area of Cagliari (Italy): management of ST-elevation myocardialinfarction, reperfusion time, and adherence to guidelines]. G Ital Cardiol(Rome). 2013 Jan;14(1):66-75. Italian. doi: 10.1714/1207.13374. PMID: 23258206. 18: Crisafulli A, Tocco F, Milia R, Angius L, Pinna M, Olla S, Roberto S,Marongiu E, Porcu M, Concu A. Progressive improvement in hemodynamic response tomuscle metaboreflex in heart transplant recipients. J Appl Physiol (1985). 2013Feb;114(3):421-7. doi: 10.1152/japplphysiol.01099.2012. Epub 2012 Nov 29. PMID:23195627. 19: Serra E, Porcu M, Minerba L, Serra S, Oppo A, Orrù P, Corda M, Atzeni F,Cappai A, Mariotti S. High prevalence of male hypogonadism and sexualdysfunction in long-term clinically stable heart transplantation recipients. IntJ Cardiol. 2012 Mar 22;155(3):476-7. doi: 10.1016/j.ijcard.2011.12.075. Epub2012 Jan 16. PMID: 22251415. 20: Senni M, Parrella P, De Maria R, Cottini C, Böhm M, Ponikowski P, FilippatosG, Tribouilloy C, Di Lenarda A, Oliva F, Pulignano G, Cicoira M, Nodari S, PorcuM, Cioffi G, Gabrielli D, Parodi O, Ferrazzi P, Gavazzi A. Predicting heartfailure outcome from cardiac and comorbid conditions: the 3C-HF score. Int JCardiol. 2013 Feb 20;163(2):206-11. doi: 10.1016/j.ijcard.2011.10.071. Epub 2011Nov 29. PMID: 22130225. 21: Carboni N, Marrosu G, Porcu M, Mateddu A, Solla E, Cocco E, Maioli MA, OppoV, Piras R, Marrosu MG. Dilated cardiomyopathy with conduction defects in apatient with partial merosin deficiency due to mutations in the laminin-α2-chaingene: a chance association or a novel phenotype? Muscle Nerve. 2011Nov;44(5):826-8. doi: 10.1002/mus.22228. PMID: 22006699. 22: Finzi AA, Latini R, Barlera S, Rossi MG, Ruggeri A, Mezzani A, Favero C,Franzosi MG, Serra D, Lucci D, Bianchini F, Bernasconi R, Maggioni AP, NicolosiG, Porcu M, Tognoni G, Tavazzi L, Marchioli R. Effects of n-3 polyunsaturatedfatty acids on malignant ventricular arrhythmias in patients with chronic heartfailure and implantable cardioverter-defibrillators: A substudy of the GruppoItaliano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca (GISSI-

343. HF) trial. Am Heart J. 2011 Feb;161(2):338-343.e1. doi:

10.1016/j.ahj.2010.10.032. PMID: 21315217. 23: Carboni N, Mura M, Marrosu G, Cocco E, Marini S, Solla E, Mateddu A, MaioliMA, Piras R, Mallarini G, Mercuro G, Porcu M, Marrosu MG. Muscle imaginganalogies in a cohort of patients with different clinical phenotypes caused byLMNA gene mutations. Muscle Nerve. 2010 Apr;41(4):458-63. doi:10.1002/mus.21514. PMID: 19882644. 24: Carboni N, Porcu M, Mura M, Cocco E, Marrosu G, Maioli MA, Solla E,Tranquilli S, Orrù P, Marrosu MG. Evolution of the phenotype in a family with anLMNA gene mutation presenting with isolated cardiac involvement. Muscle Nerve.2010 Jan;41(1):85-91. doi: 10.1002/mus.21443. PMID: 19768759. 25: Maggioni AP, Fabbri G, Lucci D, Marchioli R, Franzosi MG, Latini R, NicolosiGL, Porcu M, Cosmi F, Stefanelli S, Tognoni G, Tavazzi L; GISSI-HFInvestigators. Effects of rosuvastatin on atrial fibrillation occurrence:ancillary results of the GISSI-HF trial. Eur Heart J. 2009 Oct;30(19):2327-36.doi: 10.1093/eurheartj/ehp357. Epub 2009 Aug 30. PMID: 19717850. 26: Marchioli R, Levantesi G, Silletta MG, Barlera S, Bernardinangeli M,Carbonieri E, Cosmi F, Franzosi MG, Latini R, Lucci D, Maggioni AP, Moretti L,Nicolosi GL, Porcu M, Rossi MG, Tognoni G, Tavazzi L; GISSI-HF Investigators.Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients withheart failure: results of the GISSI-HF trial. Expert Rev Cardiovasc Ther. 2009Jul;7(7):735-48. doi: 10.1586/erc.09.70. PMID: 19589110. 27: Boccanelli A, Mureddu GF, Cacciatore G, Clemenza F, Di Lenarda A, Gavazzi A,Porcu M, Latini R, Lucci D, Maggioni AP, Masson S, Vanasia M, de Simone G; AREAIN-CHF Investigators. Anti-remodelling effect of canrenone in patients with mildchronic heart failure (AREA IN-CHF study): final results. Eur J Heart Fail. 2009Jan;11(1):68-76. doi: 10.1093/eurjhf/hfn015. PMID: 19147459. 28: Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, LucciD, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators. Effect of n-3polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HFtrial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct4;372(9645):1223-30. doi: 10.1016/S0140-6736(08)61239-8. Epub 2008 Aug 29. PMID:18757090. 29: Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, LucciD, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators. Effect ofrosuvastatin in patients with chronic heart failure (the GISSI-HF trial): arandomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct4;372(9645):1231-9. doi: 10.1016/S0140-6736(08)61240-4. Epub 2008 Aug 29. PMID:18757089. 30: Boccanelli A, Cacciatore G, Mureddu GF, de Simone G, Clemenza F, De Maria R,Di Lenarda A, Gavazzi A, Latini R, Masson S, Porcu M, Vanasia M, Gonzini L,Maggioni AP. Baseline characteristics of patients recruited in the AREA IN-CHFstudy (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenonein Mild Chronic Heart Failure). J Cardiovasc Med (Hagerstown). 2007Sep;8(9):683-91. doi: 10.2459/JCM.0b013e3281053a9a. PMID: 17700397. 31: Porcu M, Landis N, Salis S, Corda M, Orrù P, Serra E, Usai B, Matta G,Galanello R. Effects of combined deferiprone and desferrioxamine iron chelatingtherapy in beta-thalassemia major end-stage heart failure: a case report. Eur JHeart Fail. 2007 Mar;9(3):320-2. doi: 10.1016/j.ejheart.2006.08.006. Epub 2006Oct 5. PMID: 17029959. 32: Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F, Porcu M;Italian survey on Acute Heart Failure Investigators. Nationwide survey on acuteheart failure in cardiology ward services in Italy. Eur Heart J. 2006May;27(10):1207-15. doi: 10.1093/eurheartj/ehi845. Epub 2006 Apr 7. PMID:16603579. 33: Opasich C, Boccanelli A, Cafiero M, Cirrincione V, Sindaco DD, Lenarda AD,Luzio SD, Faggiano P, Frigerio M, Lucci D, Porcu M, Pulignano G, Scherillo M,Tavazzi L, Maggioni AP; BRING-UP 2 Investigators. Programme to improve the useof beta-blockers for heart failure in the elderly and in those with severesymptoms: results of the BRING-UP 2 Study. Eur J Heart Fail. 2006Oct;8(6):649-57. doi: 10.1016/j.ejheart.2005.11.005. Epub 2006 Feb 8. PMID:16466962. 34: Corda M, Orrù P, Saiu F, Giardina G, Pani A, Salis S, Porcu M. Lo scompensocardiaco diastolico: aspetti clinici, fisiopatologici e terapeutici [Diastolicheart failure]. G Ital Nefrol. 2006 Jan-Feb;23 Suppl 34:S38-43. Italian. PMID:16633993. 35: Cecchi F, Olivotto I, Betocchi S, Rapezzi C, Conte MR, Sinagra G, Zachara E,Gavazzi A, Rordorf R, Carnemolla G, Porcu M, Nistri S, Gruppillo P, Giampaoli S.The Italian Registry for hypertrophic cardiomyopathy: a nationwide survey. AmHeart J. 2005 Nov;150(5):947-54. doi: 10.1016/j.ahj.2005.01.005. PMID: 16290970. 36: Senni M, De Maria R, Gregori D, Gonzini L, Gorini M, Cacciatore G, GavazziA, Pulignano G, Porcu M, Maggioni AP. Temporal trends in survival andhospitalizations in outpatients with chronic systolic heart failure in 1995 and

1999. J Card Fail. 2005 May;11(4):270-8. doi: 10.1016/j.cardfail.2004.11.003.

PMID: 15880335. 37: Schillaci G, Di Luzio S, Coluccini M, Gonzini L, Porcu M, Pozzar F, MaggioniAP; Italian Network of Congestive Heart Failure Registry. A low pulse pressureis an independent predictor of mortality in heart failure: data from a largenationwide cardiology database (IN-CHF Registry). Ital Heart J. 2004Dec;5(12):892-8. PMID: 15706993. 38: Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R,Nicolosi GL, Porcu M; GISSI-HF Investigators. Rationale and design of the GISSIheart failure trial: a large trial to assess the effects of n-3 polyunsaturatedfatty acids and rosuvastatin in symptomatic congestive heart failure. Eur JHeart Fail. 2004 Aug;6(5):635-41. doi: 10.1016/j.ejheart.2004.03.001. PMID:15302013. 39: Di Lenarda A, Scherillo M, Maggioni AP, Acquarone N, Ambrosio GB,Annicchiarico M, Bellis P, Bellotti P, De Maria R, Lavecchia R, Lucci D, MathieuG, Opasich C, Porcu M, Tavazzi L, Cafiero M; TEMISTOCLE Investigators. Currentpresentation and management of heart failure in cardiology and internal medicinehospital units: a tale of two worlds–the TEMISTOCLE study. Am Heart J. 2003Oct;146(4):E12. doi: 10.1016/S0002-8703(03)00315-6. PMID: 14564335. 40: Baldasseroni S, Gentile A, Gorini M, Marchionni N, Marini M, Masotti G,Porcu M, Maggioni AP; Italian Network on Congestive Heart Failure Investigators.Intraventricular conduction defects in patients with congestive heart failure:left but not right bundle branch block is an independent predictor of prognosis.A report from the Italian Network on Congestive Heart Failure (IN-CHF database).Ital Heart J. 2003 Sep;4(9):607-13. PMID: 14635378. 41: Bobbio M, Ferrua S, Opasich C, Porcu M, Lucci D, Scherillo M, Tavazzi L,Maggioni AP; BRING-UP Investigators. Survival and hospitalization in heartfailure patients with or without diabetes treated with beta-blockers. J CardFail. 2003 Jun;9(3):192-202. doi: 10.1054/jcaf.2003.31. PMID: 12815569. 42: Mangia R, Senni M, Cacciatore G, Del Sindaco D, Pozzi R, Di Lenarda A, OlivaF, Clemenza F, Porcu M. E tempo di organizzare una “nuova” lotta allo scompensocardiaco? [Is it time to organize a “new ” campaign against congestive heartfailure?]. Ital Heart J Suppl. 2003 Mar;4(3):232-6. Italian. PMID: 12784758. 43: Porcu M, Opasich C, Scherillo M, Lucci D, De Maria R, Di Tano G, MaggioniAP; Italian Network on Congestive Heart Failure (IN-CHF) Investigators.Improving practice patterns in heart failure through a national cardiologicalnetwork: the case of ACE-inhibitors. Ital Heart J. 2002 Dec;3(12):730-7. PMID:12611125. 44: Tarantini L, Faggiano P, Senni M, Lucci D, Bertoli D, Porcu M, Opasich C,Tavazzi L, Maggioni AP. Clinical features and prognosis associated with apreserved left ventricular systolic function in a large cohort of congestiveheart failure outpatients managed by cardiologists. Data from the ItalianNetwork on Congestive Heart Failure. Ital Heart J. 2002 Nov;3(11):656-64. PMID:12506524. 45: Baldasseroni S, De Biase L, Fresco C, Marchionni N, Marini M, Masotti G,Orsini G, Porcu M, Pozzar F, Scherillo M, Maggioni AP; Italian Network onCongestive Heart Failure. Cumulative effect of complete left bundle-branch blockand chronic atrial fibrillation on 1-year mortality and hospitalization inpatients with congestive heart failure. A report from the Italian network oncongestive heart failure (in-CHF database). Eur Heart J. 2002 Nov;23(21):1692-8.doi: 10.1053/euhj.2001.3157. PMID: 12398827. 46: Porcu M, Cacciatore G. Strategie di intervento nello scompenso cardiacorefrattario [Intervention strategies in refractory heart failure]. Ital Heart JSuppl. 2002 Aug;3(8):791-2. Italian. PMID: 12407833. 47: Porcu M. The pharmacological treatment of heart failure: are we looking atthe sunset of the neurohormonal hypothesis. Ital Heart J. 2002 Jul;3(7):437-8.PMID: 12189976. 48: Del Sindaco D, Pulignano G, Porcu M, Scherillo M, Leggio F, Maggioni AP. Ilpaziente anziano con scompenso cardiaco nelle strutture cardiologicheospedaliere [The elderly patient with heart failure at hospital cardiologyunits]. Ital Heart J Suppl. 2002 Feb;3(2):145-53. Italian. PMID: 11926020. 49: Pulignano G, Del Sindaco D, Tavazzi L, Lucci D, Gorini M, Leggio F, Porcu M,Scherillo M, Opasich C, Di Lenarda A, Senni M, Maggioni AP; IN-CHFInvestigators. Clinical features and outcomes of elderly outpatients with heartfailure followed up in hospital cardiology units: data from a large nationwidecardiology database (IN-CHF Registry). Am Heart J. 2002 Jan;143(1):45-55. doi:10.1067/mhj.2002.119608. PMID: 11773911. 50: De Maria R, Di Lenarda A, Gavazzi A, Porcu M, Sinagra G, Parolini M; SPIC(Italian Multicenter Cardiomyopathy Study) Group. Metoprolol-induced functionalbenefit in dilated cardiomyopathy is sustained over four years and favorablyinfluences outcome. Ital Heart J. 2001 Feb;2(2):130-8. PMID: 11256541. 51: Porcu M, Orrù P. Effetti acuti emodinamici e clinici di un nuovo inotropo,il levosimendan, in pazienti con scompenso cardiaco avanzato [Acute hemodynamicand clinical effects of a new inotropic agent, levosimendan, in patients withsevere heart failure]. Ital Heart J Suppl. 2001 Feb;2(2):205-6. Italian. PMID:11255888. 52: Porcu M, Orrù P. Il ruolo attuale degli antagonisti dell’angiotensina II neltrattamento dello scompenso cardiaco [Current role of angiotensin II antagonistsin the treatment of heart failure]. Ital Heart J Suppl. 2000 Sep;1(9):1213-4.Italian. PMID: 11140296. 53: Gavazzi A, De Maria R, Parolini M, Porcu M. Alcohol abuse and dilatedcardiomyopathy in men. Am J Cardiol. 2000 May 1;85(9):1114-8. doi:10.1016/s0002-9149(00)00706-2. PMID: 10781762. 54: Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J,Vidaillet HJ Jr, Spudich S, De Girolami U, Seidman JG, Seidman C, Muntoni F,Müehle G, Johnson W, McDonough B. Missense mutations in the rod domain of thelamin A/C gene as causes of dilated cardiomyopathy and conduction-systemdisease. N Engl J Med. 1999 Dec 2;341(23):1715-24. doi:10.1056/NEJM199912023412302. PMID: 10580070. 55: Muntoni F, Ferlini A, Sewry C, Mateddu A, Marrosu G, Porcu M, Di Lenarda A,Sinagra G, Mestroni L. Dilated cardiomyopathy and muscular dystrophies: whichlesson can be learned? Cardiologia. 1999 Dec;44 Suppl 1(Pt 1):209-11. PMID:12497909. 56: Muntoni F, Di Lenarda A, Porcu M, Sinagra G, Mateddu A, Marrosu G, FerliniA, Cau M, Milasin J, Melis MA, Marrosu MG, Cianchetti C, Sanna A, Falaschi A,Camerini F, Giacca M, Mestroni L. Dystrophin gene abnormalities in two patientswith idiopathic dilated cardiomyopathy. Heart. 1997 Dec;78(6):608-12. doi:10.1136/hrt.78.6.608. PMID: 9470882; PMCID: PMC1892323. 57: Gavazzi A, De Maria R, Porcu M, Beretta L, Casazza F, Castelli G, Luvini M,Parodi O, Recalcati F, Renosto G, et al. Cardiomiopatia dilatativa: una nuovastoria naturale? L’esperienza dello Studio Policentrico Italiano Cardiomiopatie(SPIC) [Dilated cardiomyopathy: a new natural history? The experience of theItalian Multicenter Cardiomyopathy Study (SPIC)]. G Ital Cardiol. 1995Sep;25(9):1109-25. Italian. PMID: 8529848. 58: Porcu M, Muntoni F, Catani G, Mereu D. Familial cardiac and skeletalmyopathy associated with desmin accumulation. Clin Cardiol. 1994May;17(5):277-9. doi: 10.1002/clc.4960170512. PMID: 8004844. 59: Muntoni F, Catani G, Mateddu A, Rimoldi M, Congiu T, Faa G, Marrosu MG,Cianchetti C, Porcu M. Familial cardiomyopathy, mental retardation and myopathyassociated with desmin-type intermediate filaments. Neuromuscul Disord. 1994May;4(3):233-41. doi: 10.1016/0960-8966(94)90024-8. PMID: 7919971. 60: Tumbarello R, Abbruzzese PA, Meloni G, Porcu M, Martelli V, Sanna A. Avariant of the scimitar syndrome with stenosed drainage of the inferior venacava. Am Heart J. 1991 Feb;121(2 Pt 1):616-8. doi: 10.1016/0002-8703(91)90742-z.PMID: 1990776. 61: Porcu M. Il Programma Nazionale di Trapianto Cardiaco [letter] [The NationalHeart Transplant Program]. G Ital Cardiol. 1990 Oct;20(10):981-2. Italian. PMID:2090540. 62: Porcu M, Meloni GF, Loi B, Tumbarello R, Cadeddu M, Lai G, Sanna A.Dissezione delle arterie coronarie secondaria ad angiografia coronaricaselettiva [Coronary artery dissection secondary to selective coronaryangiography]. Radiol Med. 1990 Mar;79(3):175-7. Italian. PMID: 2336478. 63: Sanna A, Porcu M, Basciu M, Floris E, Martelli V. Left atrial myxomasimulating a systemic disease with pleural-pericardial effusion. Detection bytwo-dimensional echocardiography. Ann Ital Med Int. 1989 Jan-Mar;4(1):44-7.PMID: 2702017. 64: Porcu M, Meloni G, Farci G, Loi B. Localizzazione idatidea nel trattoprossimale del ramo destro dell’arteria polmonare. Descrizione di un caso[Hydatid localization in the proximal tract of the right branch of the pulmonaryartery. Description of a case]. G Ital Cardiol. 1988 May;18(5):398-9. Italian.PMID: 3192046. 65: Sanna A, Martelli V, Meloni GF, Crabu E, Porcu M, Basciu M, Mereu D.Inadeguatezza dei parametri ecocardiografici M-mode nella valutazione del gradodi stenosi mitralica. Confronto con i dati intraoperatori [Inadequacy of M-modeechocardiographic parameters in evaluating the degree of mitral stenosis.Comparison with intraoperative findings]. Minerva Cardioangiol. 1987Mar;35(3):123-31. Italian. PMID: 3587663.